Genocea Biosciences Inc GNCAQ
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- — / —
- Shares Outstanding
- 58.78M
- Market Cap
- $58.78
- Volume/Avg
- 12,140 / 8,560
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens , that drive pro-tumor immune responses.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 74
- Website
- https://www.genocea.com
Valuation
|
Metric
|
GNCAQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GNCAQ
|
|---|---|
Quick Ratio | 1.12 |
Current Ratio | 1.35 |
Interest Coverage | −33.66 |
Quick Ratio
GNCAQ
Profitability
|
Metric
|
GNCAQ
|
|---|---|
Return on Assets (Normalized) | −81.83% |
Return on Equity (Normalized) | −316.05% |
Return on Invested Capital (Normalized) | −148.28% |
Return on Assets
GNCAQ
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|><Q$%#X | LOCK|vt&g | $126B | |||
| Moderna Inc
MRNA
| LOCK|n<Q&Zx | LOCK|<lT | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|?TlKL<S | LOCK|%H&rY | $80B | |||
| argenx SE ADR
ARGX
| LOCK|LLxCK@ | LOCK|LbH | $53B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|f#@>cs | LOCK|RC | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|^kqY?c | LOCK|>K@h | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|Bz#VWJy | LOCK|%^%# | $26B | |||
| Incyte Corp
INCY
| LOCK|&NBPXG | LOCK|Bx | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|%?!?<Q | LOCK|Fh | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|jv!DSws | LOCK|hB | $14B |
United States